3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Hepatocellular
37
Liver Neoplasms
18
Neoplasm Metastasis
17
Colorectal Neoplasms
13
Cholangiocarcinoma
11
Pancreatic Neoplasms
9
Lung Neoplasms
8
Colonic Neoplasms
8
Breast Neoplasms
8
Barrett Esophagus
7
Recurrence
6
Carcinoma, Renal Cell
6
Carcinoma, Non-Small-Cell Lung
6
Thyroid Neoplasms
5
Rectal Neoplasms
5
Thyroid Nodule
4
Pain
4
Neoplasms
4
Kidney Neoplasms
4
Esophageal Neoplasms
4
Thyroid Cancer, Papillary
3
Biliary Tract Neoplasms
3
Agnosia
3
Thyroid Diseases
2
Prostatic Neoplasms
2
Leiomyoma
2
Hyperaldosteronism
2
Cancer Pain
2
Bile Duct Neoplasms
2
Uterine Cervical Neoplasms
1
Interventions
Everolimus
8
Temozolomide
7
Sunitinib
6
Specimen Handling
4
Octreotide
4
Magnetic Resonance Spectroscopy
4
Fluorouracil
4
Capecitabine
4
lutetium Lu 177 dotatate
3
Leucovorin
3
sargramostim
2
montanide ISA 51
2
incomplete Freund's adjuvant
2
cabozantinib
2
Thalidomide
2
Streptozocin
2
Oxaliplatin
2
Irinotecan
2
Injections
2
Doxorubicin
2
Cytoreduction Surgical Procedures
2
Colony-Stimulating Factors
2
Bevacizumab
2
surufatinib
1
sapanisertib
1
recombinant interferon alpha 2b-like protein
1
pentetreotide
1
pasireotide
1
nimotuzumab
1
napabucasin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Adenoma, Islet Cell
×
Radiofrequency Ablation
×
Clear all
NCT04520932
2025-05-25
RFANET
Institut Paoli-Calmettes
Phase NA
Recruiting
82 enrolled